Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation Of Past TOPAMAX(R) Marketing And Promotional Activities
April 30, 2010 – 11:21 pmOrtho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) announced an agreement with the U.S. Attorney’s Office for the District of Massachusetts, the U.S. Department of Justice, and other federal agencies to resolve a previously reported government investigation of past U.S. marketing and promotional practices for TOPAMAX® (topiramate), an antiepileptic and migraine prevention prescription medicine. Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been cooperating with the government since its investigation began in December 2003…
Find more info about Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation Of Past TOPAMAX(R) Marketing And Promotional Activities photos videos pictures. read more
Related Info :
Tags: Activities, Antiepileptic, Department Of Justice, District Of Massachusetts, Government Investigation, Inc., Investigation, Janssen Pharmaceuticals, Marketing, Marketing Activities, Mcneil Pharmaceuticals, Medicine, Migraine, Migraine Prevention, Ortho Mcneil Janssen, OrthoMcNeilJanssen, past, Pharmaceuticals, Pharmaceuticals Inc, Photos, Prescription Medicine, Prevention Prescription, Promotional, Promotional Activities, Resolves, Topamax, Topamax Topiramate, TOPAMAXR, U S Department
Sorry, comments for this entry are closed at this time.